SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abbott Laboratories and Enanta Pharmaceuticals, Inc. Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor